Members of the Board - Fermenta Biotech Ltd

Global Channel Partners | Awards & Recognitions
Home Contact Us Sitemap
Vitamin D3 and Penicillin G Acylase
Members of Board Fermenta Biotech

Mr. Peter Bains - Chairman, Non Executive Independent Director

Peter BainsMr Peter Bains, is Non Executive Chairman of Fermenta Biotech Ltd.

Mr Bains is a vastly experienced life science executive and leader, built on a two decade career with the MNC major Glaxo SmithKline in which he held a number of senior and global roles spanning multiple geographies, functions and businesses.

Prior to joining Fermenta, Mr. Bains served as Senior Vice President, Global Marketing of SmithKline Beecham and latterly as Senior Vice President, International Commercial Operations, GlaxoSmithKline. He was also a Non-Executive Director of Glaxosmithkline Pharmaceuticals India Ltd. from July 26, 2005 to July 27, 2009.

During his tenure with Glaxosmithkline, Mr Bains played an important role in building and establishing several major GSK brands as market leaders and was also instrumental in conceiving, developing and implementing the organizational redesign in GSK’s International operations. Peter held key leadership roles and responsibilities in the pharmaceuticals and vaccines operational strategy, planning and execution in Latin America, Middle East, South-East Asia, Australia China, and Canada. He was also a Member of various senior GSK management teams with strategic, operations, marketing, and business development responsibilities.

Since 2009, Mr. Bains has been a consultant, specializing in supporting strategic growth opportunities in small- and medium-sized innovation-based life science companies. He currently also serves on the board of Syngene International Limited, India’s largest CRO and Sosei, a Japanese listed biotech company.

Mr. Bains graduated from the University of Sheffield, with a BSc Combined Honours degree in Physiology and Zoology.

Members of Board FBL

Mr. Satish Varma - Managing Director

Satish VarmaMr. Satish Varma is the Managing Director of Fermenta Biotech Limited (FBL), having been appointed to this office with effect from May 2010. Mr. Varma has been a Board Director of Fermenta Biotech Limited since 2004.

Satish joined the DIL group as the Executive Assistant to the then Managing Director and Founder in 1995. In this role Satish garnered extensive and diverse operational, management and legal experience across the full scope of the DIL enterprise and was instrumental in the Solvay demerger in 2000 as well as the Crocin brand outlicence in 1996, events that have shaped the current strategic FBL platform. Satish took direct operational responsibility of the Vitamin D3 business in 1998 and has led its growth since.

As Managing Director since 2010, Satish now oversees the entire operations of the company and is an integral part of the strategy and management team. He has played a leading role in the strategic planning and execution of FBL’s transformation to a diverse and focused world-class research centric organization reaching out to global markets and customers.

Satish Varma now leads a team of more than 300 employees based in India, with plans to expand geographically and enter emerging markets shortly.

In addition to his Executive Board duties, Satish is also a member of the Shareholders'/ Investor's Grievance Committees of DIL Limited and Fermenta Biotech Limited and a member of the Audit Committees of Fermenta Biotech Limited.

Members of Board FBL

Ms. Anupama Datla - Executive Director

Anupama DatlaMs. Anupama Datla, has been an Executive Board Director of Fermenta Biotech Limited since 2007.

Anupama has worked for FBL since 2006 and since then has taken executive leadership for FBL’s R&D division. Under Anupama’s guidance FBL has evolved from a simple bulk drug manufacturer, into a discovery and development based, specialized and diverse biotechnology company engaged in novel discovery, formulation and process development platforms. Under Ms. Datla’s supervision, research and development has now underpinned FBL with a sustainable pipeline of opportunities for new and novel growth opportunities.

In addition to her R&D responsibilities Anupama is also responsible for quality control and implementation of safety policies and procedures across the organization.

She is the author of various patents within the Group, is in charge of introducing and implementing new technology platforms into the company and also spearheads the new business development, customer interaction and marketing in India and overseas.

Anupama is a Post-Graduate in Biotechnology from the Mumbai University and a Science Graduate from the Boston College, USA.

Members of Board FBL

Mr. Krishna Datla - Non Executive Director

Krishna DatlaMr. Krishna Datla, is the Promoter Director of Fermenta Biotech Limited (FBL). Krishna took over the reigns of the company from his father, the late Mr. Vasant Kumar Datla, at a young age of 24 years.

He has played a key role in the development and building-up of the diversified businesses of FBL for well over 12 years now. He has been credited with the integration of businesses across the various group companies, infusing a strong sense of global vision thereby opening the opportunities across International markets including highly regulated destinations.

Krishna was instrumental in streamlining and improving the human resource, sales, marketing and client acquisition processes within the organisation. He brought in a highly skilled leadership team and also enhanced the overall landscape of the Infrastructure, product and service capabilities, thus strengthening the approach and the outlook for the future.

Krishna also serves as Managing Director of DIL Ltd.

He is a Commerce Graduate from Mumbai University.

Members of Board FBL

Mr. Sanjay Buch - Non Executive Independent Director

Sanjay BuchMr. Sanjay Buch, a Practising Advocate and Solicitor, is a partner at Crawford Bayley & Co., a respected firm of advocates and solicitors, headquartered in Mumbai. He is practicing for past two decades and is involved in a wide spectrum of legal work ranging from corporate and business laws and specializes in Business Restructuring, Mergers and Acquisitions and advises several companies including large domestic and international corporations established in India. Mr. Sanjay Buch is the Non-Executive Director and member of various committees of the Board of Directors of the Company.

Members of Board FBL

Mr. Viswanath Chibrolu - Non Executive Director

Viswanath ChibroluMr. Viswanath Chibrolu is the Managing Director of InvAscent India, focusing on Life Sciences and Healthcare sector. Prior to that, Mr. Viswanath Chibrolu worked with SilverCreek Capital, a USD 5 billion fund of hedge funds, where in addition to heading risk management he has also been active in structuring and conducting due diligence on direct investments. Prior to SilverCreek, he was with McKinsey’s Investment Office where he led the initiative in direct investments in the insurance space after having been a general consultant serving clients in multiple sectors helping them improve operational efficiency. Mr. Viswanath Chibrolu holds an MBA from the Indian Institute of Management, Lucknow and wrote his PhD thesis at Case Western Reserve University where he focused on pricing derivatives and real options.

Members of Board FBL

Mr. T. P. Devarajan - Alternate (Non Executive) Director to Mr. Viswanath Chibrolu

T.P. DevarajanMr. T.P. Devarajan is a Director (Investments) in InvAscent Advisory Services India Private Limited, an Advisory company which supports Private Equity firms making investments in the Indian Life Sciences Sector since 2007. He has over 15 years of experience in financial service sector across sectors such as Investment Banking and Corporate Finance. He is a Chemical Engineer by training with a post graduate Degree in Management from the Indian Institute of Management, Ahmedabad.

Members of Board FBL

Dr.Gopakumar Nair - Non-Executive Independent Director

T.P. Devarajan

Dr. Gopakumar G. Nair is an Intellectual Property Rights Consultant and practicing Patent Attorney. He is also a practicing lawyer specialising in Mediation and Arbitration as well as in licensing and technology transfer. Dr Nair has been associated with pharmaceutical industry for more than four decades as Director, Managing Director & Chairman of various public limited pharmaceutical companies and served Industry Associations in various capacities. Dr. Nair has many articles and publications to his credit, including valid granted Indian patent, as inventor.

Mr. Nair is a Ph.D from National Chemical Laboratory (NCL), Pune and has Diploma in Management & Patent Law. Dr. Nair is also a Law (LL.B) graduate from Mumbai University..

Click here to download the Independent Director Appointment Letter Template document.

FBL News & Events Meet us at CPhI worldwide - Fira de Barcelona Gran Via Con, Spain - 04 - 06 October 2016
Fermenta Biotech Ltd invites you at CPhI Worldwide  - Fira de Barcelona Gran Via Con,...
Meet us at CPhI worldwide - Feria de Madrid, Spain - 13 - 15 October 2015
  Fermenta Biotech Ltd invites you at CPhI Worldwide  - Feria de Madrid, Spain&nbs...
Article in Modern Pharma - Peter Bains
Green manufacturing in Pharma : On an Impact Mode, Peter Bains, Chairman - Fermenta Biotech Ltd ...
Business Division
Penicilling AcylaseSilicon PowderVitamin D3Bioremediation

Fermenta Biotech Ltd